000 01306 a2200337 4500
005 20250513204834.0
264 0 _c20000421
008 200004s 0 0 eng d
022 _a0732-183X
024 7 _a10.1200/JCO.2000.18.7.1558
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWolff, A C
245 0 0 _aPrimary systemic therapy in operable breast cancer.
_h[electronic resource]
260 _bJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_cApr 2000
300 _a1558-69 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aBiomarkers, Tumor
_xanalysis
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aPredictive Value of Tests
650 0 4 _aPrognosis
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aRisk Factors
650 0 4 _aTreatment Outcome
700 1 _aDavidson, N E
773 0 _tJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_gvol. 18
_gno. 7
_gp. 1558-69
856 4 0 _uhttps://doi.org/10.1200/JCO.2000.18.7.1558
_zAvailable from publisher's website
999 _c10689444
_d10689444